Pasithea Therapeutics Corp. Warrant (NASDAQ: KTTAW) last traded at $0.00300. The quote above updates while this page is open; the figures below are drawn from Pasithea Therapeutics Corp. Warrant’s own filings and are restated only when a new one is published.
Pasithea Therapeutics Corp. Warrant trades on NASDAQ under the ticker KTTAW. Its market capitalisation is $100,243.344.
Valuation measures for Pasithea Therapeutics Corp. Warrant, derived from the latest quote and its most recent SEC filing.
| Market cap | $100.2K |
|---|---|
| Enterprise value | -$43.69M |
| Price / book | 0.00 |
Trailing-twelve-month figures tagged in Pasithea Therapeutics Corp. Warrant's XBRL filings with the SEC.
| Net income (TTM) | -$20.43M |
|---|---|
| EPS (TTM) |
| -$0.920 |
| Return on equity | -40.99% |
|---|
| Cash | $45.66M |
|---|
Range and volume for KTTAW over the past 52 weeks.
| 52-week high | $0.00300 |
|---|---|
| 52-week low | $0.00300 |
| Volume | 383 |
| Average volume | 383 |
| Previous close | $0.00 |
Invest a chosen dollar amount in Pasithea Therapeutics Corp. Warrant with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell KTTAW.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.